VVOSVivos Therapeutics, Inc.May 21, 2026Q1 2026
Read transcript →Vivos Therapeutics, Inc. (VVOS) Earnings Call Transcripts
NASDAQ·Healthcare·Medical - Devices
$0.43
+2.09%
Mkt Cap $7.83M
VVOSVivos Therapeutics, Inc.May 21, 2026VVOSVivos Therapeutics, Inc.Apr 15, 2026Q4 2025
Read transcript →VVOSVivos Therapeutics, Inc.Nov 19, 2025Q3 2025
Read transcript →VVOSVivos Therapeutics, Inc.Aug 19, 2025Q2 2025
Read transcript →VVOSVivos Therapeutics, Inc.May 15, 2025Q1 2025
Read transcript →VVOSVivos Therapeutics, Inc.Apr 1, 2025Q4 2024
Read transcript →VVOSVivos Therapeutics, Inc.Nov 14, 2024Q3 2024
Read transcript →VVOSVivos Therapeutics, Inc.Aug 15, 2024Q2 2024
Read transcript →VVOSVivos Therapeutics, Inc.May 14, 2024Q1 2024
Read transcript →VVOSVivos Therapeutics, Inc.Mar 28, 2024Q4 2023
Read transcript →VVOSVivos Therapeutics, Inc.Nov 17, 2023Q3 2023
Read transcript →VVOSVivos Therapeutics, Inc.Aug 16, 2023Q2 2023
Read transcript →VVOSVivos Therapeutics, Inc.Jun 8, 2023Q1 2023
Read transcript →VVOSVivos Therapeutics, Inc.Mar 31, 2023Q4 2022
Read transcript →VVOSVivos Therapeutics, Inc.Dec 20, 2022Q3 2022
Read transcript →VVOSVivos Therapeutics, Inc.May 16, 2022Q1 2022
Read transcript →VVOSVivos Therapeutics, Inc.Mar 31, 2022Q4 2021
Read transcript →VVOSVivos Therapeutics, Inc.Nov 15, 2021Q3 2021
Read transcript →VVOSVivos Therapeutics, Inc.Aug 12, 2021Q2 2021
Read transcript →VVOSVivos Therapeutics, Inc.May 18, 2021Q1 2021
Read transcript →